| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 5,940 | $40 | $225.7K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 77,040 | $1 | $77K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 640 | $100 | $61.8K |
| J0897 | Injection, denosumab, 1 mg | 2,880 | $20 | $51.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 190 | $150 | $28.2K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 300 | $80 | $24.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 210 | $110 | $23.7K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 1,840 | $10 | $11K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 120 | $70 | $7.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 140 | $50 | $7.5K |